SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting stellar positive Phase 2 results for sonelokimab in axial spondyloarthritis, which the community views as potentially best-in-class with deep biologic activity. High anticipation for its upcoming Investor Day, coupled with significant institutional re-accumulation and existing short interest, is fueling widespread discussion of the stock's undervaluation and potential for a substantial rally or even a buyout.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MULN crypto token is trending, frequently confused with the highly controversial Mullen Automotive stock, leading to a polarized community discussion; while a small group attempts to rally a "Mullen Army" with claims of utility, the broader sentiment warns of it being a "scam coin" with extremely low volume and potential for further decline.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group (DJT) is trending after the Supreme Court's ruling on tariffs prompted Donald Trump to announce an immediate increase in global tariffs to 15%, fueling intense debate on his economic policies and their potential impact. The community remains sharply divided, discussing whether this move is a strategic victory or a detrimental policy that could impact the broader economy, alongside ongoing speculation about the stock's underlying financials.

We're a deflationary token that builds utility around our BTC and ETH reserves.  Our main goal is to onboard newbies in the friendliest and safest way, that's why we launched our NFT book (definitely for dummies) on five chains one year ago.  Our new swap generates revenue that combined with our taxes allow us to grow at a slow but steady pace; We're completely sustainable because our monthly expenses are really low.

PiggyCoinBSC

PiggyCoinBSC is trending due to robust community engagement through frequent 'community spaces' on X and Cryptotwits, where a predominantly bullish sentiment is expressed. Discussions center on its unique tokenomics, which include Bitcoin and Ethereum Strategic Reserves, USDC rewards for holders, a buyback and burn mechanism, and its newly launched multi-chain swap platform, Swappy.cool, all contributing to its perceived long-term potential within DeFi.

Pattern Group, Inc. accelerates brands on global ecommerce marketplaces by leveraging proprietary technology and AI. It acquires inventory from brand partners to sell to consumers through online marketplaces, utilizing vast data sets, sophisticated machine learning, and AI models. The company optimizes and automates all levers of ecommerce growth for global brands, enabling full control over advertising, content management, logistics and fulfillment, pricing, forecasting, and customer service. Pattern Group was founded by David Wright and Melanie Alder in 2013 and is headquartered in Lehi, UT.

Pattern Group Inc. - Ordinary Shares - Series A

Pattern Group

Pattern Group is trending as Amazon's upcoming discontinuation of FBA Prep Services positions PTRN to capture significant market share in e-commerce fulfillment and logistics for global brands. Bullish investors highlight strong earnings, strategic AI-driven acquisitions, and perceived undervaluation, while others debate the company's long-term dependency on marketplace giants.

Ciena Corp. is a network technology company, which engages in the provision of hardware, software, and services to network operators, as well as enabling enhanced network capacity, service delivery, and automation. It operates through the following segments: Networking Platforms, Platform Software and Services, Blue Planet Automation Software and Services, and Global Services. The Networking Platforms segment consists of converged packet optical and packet networking portfolios. The Platform Software and Services segment provides analytics, data, and planning tools to assist customers in managing its networking platforms products. The Blue Planet Automation Software and Services segment enables customers to implement large-scale software and IT-led OSS transformations by transforming legacy networks into service ready networks. The Global Services segment offers a broad suite of value-added services. The company was founded by Patrick H. Nettles and Kevin Brian Kimberlin in 1992 and is headquartered in Hanover, MD.

CIENA Corp.

Ciena is actively discussed for its recent S&P 500 inclusion and strong financial performance, fueled by soaring demand for high-speed optical networking and data center interconnects critical to powering AI and cloud infrastructure. The community sees Ciena as providing the essential 'AI plumbing,' with ongoing debate about its rapid ascent and the broader tailwinds benefiting the optical sector.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following the FDA approval of BYSANTI, its second major drug approval in two months, igniting widespread community speculation about its long-term revenue potential and a significant buyout from major pharmaceutical companies seeking to fill patent cliffs, especially given the anticipated blockbuster impact of its Tradipitant pipeline.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

BITI is trending as the community debates allegations connecting Jeffrey Epstein's criminal activities to early Bitcoin funding, fueling a strong sentiment that Bitcoin, now widely called "pedo-currency," is destined for zero.

MeiraGTx Holdings Plc is a clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It targets local delivery of small doses of genetic medicines to treat both inherited and more common conditions with severe unmet needs. The company was founded on March 20, 2015 and is headquartered in New York, NY.

MeiraGTx Holdings plc

MeiraGTx Holdings is attracting attention as an undervalued gene therapy player following recent collaborations with Eli Lilly for an ophthalmology program and Hologen AI, which includes substantial funding for its promising Parkinson's disease treatment. The community is actively discussing the potential for significant partnerships and future growth driven by these advancements and strong clinical data.

StealthGas, Inc. engages in the provision of international energy seaborne transportation services to liquefied petroleum gas sectors. It owns fleet of vessels that carry petroleum and petrochemical gas products in liquefied form such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer. The company was founded in December 22, 2004 and is headquartered in Athens, Greece.

StealthGas Inc

StealthGas (GASS) is trending due to strong financial results, including record quarterly profits and an increased share repurchase program, positioning it favorably within a cyclical LPG shipping market experiencing rising demand and shipping rates. The community is actively discussing its perceived undervaluation and relative stability compared to related entities, though some remain cautious about long-term consistency.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options...

Here's How Veracyte Stock Is Placed Ahead of Q4 Earnings

VCYT heads into Q4 earnings with rising estimates, strong Decipher and Afirma volumes, and revenues seen up nearly 17% year over year.

Bastion Asset Management Inc. Buys 304,960 Shares of AngioDynamics, Inc. $ANGO

Bastion Asset Management Inc. boosted its position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 31.8% in the third quarter, according to its most recent disclosure with the Securities and...

Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y

WAT tops Q4 estimates as revenues rise 7% Y/Y, with strong Pharma and Europe growth, and upbeat 2026 sales and earnings outlook.

DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth

DXCM beats Q4 EPS estimates, posts 13% revenue growth and reiterates 2026 guidance as G7 15 Day rollout and margin gains drive momentum.

Essex Investment Management Co. LLC Increases Holdings in AngioDynamics, Inc. $ANGO

Essex Investment Management Co. LLC lifted its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 41.9% during the third quarter, according to its most recent 13F filing with...

AngioDynamics, Inc. (NASDAQ:ANGO) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five research firms that are presently covering the firm, MarketBeat.com...

Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect?

The mean of analysts' price targets for AngioDynamics (ANGO) points to a 92.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

AngioDynamics (ANGO) Down 3.9% Since Last Earnings Report: Can It Rebound?

AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AngioDynamics and The PERT Consortium Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The Med Tech segment consists of technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment focuses on core, venous, ports, and other oncology products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

Current Price	$11.22
Prev Close	$11.20
Open	$11.34
Dividend Yield	0.00%
50-Day Moving Average	$11.53
Beta	1.04
Avg. Volume	903,575.45
PE Ratio	-16.67

52-Week High	$13.99
52-Week Low	$8.27
Market Capitalization	$466.61M
EPS (Annual)	-$0.8321
Price to Book	2.65
Revenue Per Employee	$433,330.37

ANGO
Angiodynamic Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANGO News

ANGOAngiodynamic Inc